Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: June 29, 2010
Last updated: June 30, 2015
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)